在非小细胞肺癌中,特定于年龄和性别的基因组资料
William Mostertz1, Marvaretta Stevenson, Chaitanya Acharya
1Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA. anil.potti@duke.edu
JAMA
|February 11, 2010
概括
基因表达概况揭示了非小细胞肺癌 (NSCLC) 中不同的分子途径,这些途径与基于患者年龄和性别的无复发生存相关. 这些途径差异为NSCLC生物学和患者结果提供了洞察力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 基因表达特征分析可以识别与患者年龄和性别相关的非小细胞肺癌 (NSCLC) 结果的差异.
- 了解这些生物差异对于个性化治疗策略至关重要.
研究的目的:
- 根据患者的年龄和性别,阐明NSCLC中临床显著的生物学区别.
- 为了确定与NSCLC无复发生存相关的基因表达特征.
主要方法:
- 787名早期NSCLC患者的瘤样本和临床数据的回顾性分析.
- 基因表达特征的应用,以识别致癌途径激活模式.
- 根据年龄 (<70 vs. ≥70岁) 和性别进行分组分析.
主要成果:
- 根据5年无复发生存期确定了不同的高风险和低风险NSCLC患者群.
- 特定通路激活 (Src,TNF,伤口愈合,侵入性,STAT3,EGFR) 与不同年龄和性别子组的风险和生存相关.
- 基于途径的亚表型独立地与女性和年轻患者 (70岁以下) 的存活率相关.
结论:
- 根据瘤途径激活配置文件定义的NSCLC患者的子组显示了与无复发生存率的关联.
- 这些发现凸显了NSCLC中基于途径的分层的潜力.
- 独立数据集的验证是必要的,以确认这些结果.
更多相关视频
04:22Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
相关概念视频
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
